COMP <GO>
GRFS vs BLTE // NET PROFIT MARGIN
Grifols S.A. (NASDAQ) VS. Belite Bio Inc (NASDAQ) • 15-METRIC TALLY: GRFS 1
— BLTE 1
■ METRIC PARITY
LAST: $8.51 (+5.06%) • MKT CAP: $5.57B
net-margins
—
LAST: $153.67 (-0.69%) • MKT CAP: $6.23B
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRFS VS. BLTE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRFS | BLTE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -15.90% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -0.61% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.8 | 50.3 | +16.50 | GRFS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.57B | $6.23B | -$662.5M | BLTE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRFS REV | BLTE REV | GRFS GROSS % | BLTE GROSS % | GRFS FCF | BLTE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $235.8M | — | — | — | -$37.1M |
| FY 2024 | — | $112.0M | — | — | — | -$29.4M |
| FY 2023 | — | $88.7M | — | — | — | -$29.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRFS // BETA —
BLTE // BETA —